Green Nanoformulations of Polyvinylpyrrolidone-Capped Metal Nanoparticles: A Study at the Hybrid Interface with Biomimetic Cell Membranes and In Vitro Cell Models.

FRAP FRET gold nanoparticles palladium nanoparticles plasmonic nanoparticles prostate cancer cells silver nanoparticles supported lipid bilayers

Journal

Nanomaterials (Basel, Switzerland)
ISSN: 2079-4991
Titre abrégé: Nanomaterials (Basel)
Pays: Switzerland
ID NLM: 101610216

Informations de publication

Date de publication:
12 May 2023
Historique:
received: 13 04 2023
revised: 06 05 2023
accepted: 11 05 2023
medline: 27 5 2023
pubmed: 27 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

Noble metal nanoparticles (NP) with intrinsic antiangiogenic, antibacterial, and anti-inflammatory properties have great potential as potent chemotherapeutics, due to their unique features, including plasmonic properties for application in photothermal therapy, and their capability to slow down the migration/invasion speed of cancer cells and then suppress metastasis. In this work, gold (Au), silver (Ag), and palladium (Pd) NP were synthesized by a green redox chemistry method with the reduction of the metal salt precursor with glucose in the presence of polyvinylpyrrolidone (PVP) as stabilizing and capping agent. The physicochemical properties of the PVP-capped NP were investigated by UV-visible (UV-vis) and attenuated total reflection Fourier transform infrared (ATR-FTIR) spectroscopies, dynamic light scattering (DLS), and atomic force microscopy (AFM), to scrutinize the optical features and the interface between the metal surface and the capping polymer, the hydrodynamic size, and the morphology, respectively. Biophysical studies with model cell membranes were carried out by using laser scanning confocal microscopy (LSM) with fluorescence recovery after photobleaching (FRAP) and fluorescence resonance energy transfer (FRET) techniques. To this purpose, artificial cell membranes of supported lipid bilayers (SLBs) made with 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (POPC) dye-labeled with 7-nitro-2-1,3-benzoxadiazol-4-yl (NBD, FRET donor) and/or lissamine rhodamine B sulfonyl (Rh, FRET acceptor) were prepared. Proof-of-work in vitro cellular experiments were carried out with prostate cancer cells (PC-3 line) in terms of cytotoxicity, cell migration (wound scratch assay), NP cellular uptake, and cytoskeleton actin perturbation.

Identifiants

pubmed: 37242040
pii: nano13101624
doi: 10.3390/nano13101624
pmc: PMC10223103
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministry of Education, Universities and Research
ID : PRIN (project code: 2017WBZFHL)
Organisme : University of Catania
ID : University of Catania (PIAno di inCEntivi per la RIcerca di Ateneo 2020/2022, Linea di intervento 1 CHANCE
Organisme : University of Catania
ID : University of Catania (PIAno di inCEntivi per la RIcerca di Ateneo 2020/2022, Linea di intervento 2 GRABIO

Références

Nanomaterials (Basel). 2021 Jan 26;11(2):
pubmed: 33530434
Spectrochim Acta A Mol Biomol Spectrosc. 2005 Oct;61(13-14):2861-6
pubmed: 16165025
Molecules. 2015 Dec 15;20(12):22476-98
pubmed: 26694334
Colloids Surf B Biointerfaces. 2013 Oct 1;110:163-70
pubmed: 23711787
Dalton Trans. 2015 Nov 7;44(41):17883-905
pubmed: 26434727
J Am Chem Soc. 2006 Feb 15;128(6):2115-20
pubmed: 16464114
Front Oncol. 2020 Oct 07;10:578418
pubmed: 33117715
Int J Nanomedicine. 2021 Apr 15;16:2849-2877
pubmed: 33883895
Biomaterials. 2009 Oct;30(31):6341-50
pubmed: 19698986
Adv Healthc Mater. 2021 May;10(10):e2002163
pubmed: 33763992
ACS Appl Bio Mater. 2023 Feb 20;6(2):819-827
pubmed: 36755401
J Nanomater. 2017;2017:
pubmed: 30034459
Front Chem. 2020 Jun 03;8:376
pubmed: 32582621
Am J Clin Exp Urol. 2022 Jun 15;10(3):142-153
pubmed: 35874285
Nanoscale Res Lett. 2014 Jan 13;9(1):17
pubmed: 24418460
Nanomaterials (Basel). 2021 Apr 09;11(4):
pubmed: 33918740
Drug Deliv. 2022 Dec;29(1):664-678
pubmed: 35209786
Nat Immunol. 2008 Sep;9(9):988-98
pubmed: 18711436
Analyst. 2014 Oct 7;139(19):4855-61
pubmed: 25096538
Polymers (Basel). 2018 Dec 03;10(12):
pubmed: 30961261
Nanotechnology. 2008 Jul 30;19(30):305603
pubmed: 21828765
Polymers (Basel). 2022 Dec 09;14(24):
pubmed: 36559766
Traffic. 2012 Dec;13(12):1589-600
pubmed: 22984916
Int J Mol Sci. 2020 Apr 27;21(9):
pubmed: 32349323
Dalton Trans. 2020 Mar 21;49(11):3510-3518
pubmed: 32107506
Aging (Albany NY). 2016 Apr;8(4):603-19
pubmed: 27019364
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6700-5
pubmed: 23569259
Pharmaceutics. 2021 May 12;13(5):
pubmed: 34066092
J Chem Biol. 2011 Oct;4(4):185-91
pubmed: 22837793
Biomaterials. 2014 Feb;35(5):1597-607
pubmed: 24290441
Environ Sci Technol. 2015 Mar 17;49(6):3813-21
pubmed: 25692749
Langmuir. 2012 May 1;28(17):6736-41
pubmed: 22509730
ACS Nano. 2020 Sep 22;14(9):12260
pubmed: 32902953
J Inorg Biochem. 2022 Jan;226:111657
pubmed: 34784565
Int J Nanomedicine. 2022 Sep 16;17:4321-4337
pubmed: 36147546
Cold Spring Harb Perspect Med. 2019 Mar 1;9(3):
pubmed: 29661810
Appl Biochem Biotechnol. 2023 Jun;195(6):3699-3718
pubmed: 35349084
Int J Mol Sci. 2022 Jan 13;23(2):
pubmed: 35055024
J Nanobiotechnology. 2020 Nov 23;18(1):172
pubmed: 33225973
Cells. 2020 Oct 06;9(10):
pubmed: 33036298
Langmuir. 2012 Nov 13;28(45):15929-36
pubmed: 23072572
Anal Chem. 2020 Dec 1;92(23):15336-15343
pubmed: 33179908
Int J Mol Sci. 2018 Jul 12;19(7):
pubmed: 30002330
Nanomedicine. 2011 Oct;7(5):580-7
pubmed: 21333757
ACS Appl Bio Mater. 2023 Feb 20;6(2):483-493
pubmed: 36651801
Int J Mol Sci. 2021 Sep 03;22(17):
pubmed: 34502495
Anal Chem. 2020 Aug 4;92(15):10693-10699
pubmed: 32567303
Chem Commun (Camb). 2019 Jun 13;55(49):6964-6996
pubmed: 31140997
Heliyon. 2022 Dec 01;8(12):e12028
pubmed: 36506385
Int J Nanomedicine. 2019 Oct 15;14:8285-8302
pubmed: 31802866
Front Cell Dev Biol. 2019 Dec 20;7:355
pubmed: 31921862

Auteurs

Alice Foti (A)

Nano Hybrid Biointerfaces Laboratory (NHBIL), Department of Chemical Sciences, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.

Luana Calì (L)

Nano Hybrid Biointerfaces Laboratory (NHBIL), Department of Chemical Sciences, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.

Salvatore Petralia (S)

Department of Drug and Health Sciences, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.

Cristina Satriano (C)

Nano Hybrid Biointerfaces Laboratory (NHBIL), Department of Chemical Sciences, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.

Classifications MeSH